GlycoMimetics' (GLYC) Neutral Rating Reaffirmed at HC Wainwright

GlycoMimetics (NASDAQ:GLYC – Get Free Report)‘s stock had its “neutral” rating reiterated by investment analysts at HC Wainwright in a research report issued on Monday, Benzinga reports. Several other research analysts also recently issued reports on the stock. StockNews.com downgraded shares of GlycoMimetics from a “hold” rating to a “sell” rating in a research report […]

Related Keywords

United States , ,Acuta Capital Partners ,Glycomimetics Company Profile ,Associates Inc ,Glycomimetics Inc ,Get Free Report ,One Financial ,Mimetics Stock Down ,Glycomimetics Daily ,Glycomimetics ,Nasdaq Glyc ,Glyc ,Medical ,Reiterated Rating ,Hc Wainwright ,